Astellas Pharma Inc., of Tokyo, engaged Citigroup Global Markets Inc. to review its strategic altertnatives with respect to Prosidion Ltd., which it acquired with OSI Pharmaceuticals in June of 2010.
To continue reading subscribe now to BioWorld Today
